BTN3A2 Protein, Human, Recombinant (His & Avi)
Product Specifications
Purity
>95%
Bioactivity
BTN3A2/BT3.2 butyrophilin mRNA expression by tumoral cells was previously identified as a prognostic factor in a small cohort of high grade serous epithelial ovarian cancer (HG-EOC) .In conclusion, BT3.2 protein is a potential prognostic biomarker for the identification of HG-EOC patients with better outcome. In contrast, high CD206 /CD68 expression is associated with high risk of disease progression.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-B447396-1MG 1 mg
Bis(4-hydroxyphenyl) Sulfone O-Beta-D-Glucuronide-13C12 Sodium Salt
Sign In for Pricing
View Details 
